Fund shareholders of Sagimet Biosciences Inc
ISIN US7867001049 · United States · LEI 2549002OT2F8BV0VPD02
- Fund shareholders
- 103
- Of which ETFs
- 18 85 other funds
- Value held
- 87.8M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 68 | 525.6 $ | 0.01 % | as of Jun 30, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 50 | 355.5 $ | 0.00 % | as of Jul 31, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 17 | 131.4 $ | 0.00 % | as of Jun 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 1.30 % | as of Jun 30, 2026 ↗ |
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 0.52 % | as of Jul 31, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.26 % | as of Jun 30, 2026 ↗ |
| iShares Health Innovation Active ETF BlackRock ETF Trust | 0.11 % | as of Jul 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.10 % | as of Jun 30, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 0.07 % | as of May 29, 2026 ↗ |
| Health Sciences Portfolio PACIFIC SELECT FUND | 0.07 % | as of Jun 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.07 % | as of Jun 30, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 0.07 % | as of Jun 30, 2026 ↗ |
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 0.06 % | as of Jul 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 103 | +64 | 11,702,739 | +167.6 % |
| 2026Q2 | 39 | +11 | 4,373,548 | +108.7 % |
| 2026Q1 | 28 | +5 | 2,095,667 | +20.6 % |
| 2025Q4 | 23 | -1 | 1,737,428 | -11.1 % |
| 2025Q3 | 24 | -4 | 1,954,698 | -0.7 % |
| 2025Q2 | 28 | +2 | 1,968,551 | -3.0 % |
| 2025Q1 | 26 | +2 | 2,030,367 | +2.5 % |
| 2024Q4 | 24 | -52 | 1,980,031 | -37.9 % |
| 2024Q3 | 76 | -11 | 3,190,526 | -26.8 % |
| 2024Q2 | 87 | +19 | 4,359,619 | +115.7 % |
| 2024Q1 | 68 | +8 | 2,021,387 | -22.7 % |
| 2023Q4 | 60 | 2,615,169 |
Institutional managers
84 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Woodline Partners LP | 1,000,943 | 5.2M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 966,253 | 5M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 952,996 | 5M $ | as of Mar 31, 2026 |
| Affinity Asset Advisors, LLC | 868,020 | 4.5M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 862,303 | 4.5M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 799,943 | 4.2M $ | as of Mar 31, 2026 |
| HHLR ADVISORS, LTD. | 724,800 | 3.8M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 625,469 | 3.3M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 411,570 | 2.2M $ | as of Mar 31, 2026 |
| Blue Owl Capital Holdings LP | 333,877 | 1.7M $ | as of Mar 31, 2026 |
| RAYMOND JAMES FINANCIAL INC | 317,550 | 1.7M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 309,522 | 1.6M $ | as of Mar 31, 2026 |
| Hudson Bay Capital Management LP | 303,223 | 1.6M $ | as of Mar 31, 2026 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 299,641 | 1.6M $ | as of Mar 31, 2026 |
| UBS Group AG | 293,934 | 1.5M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 271,217 | 1.4M $ | as of Mar 31, 2026 |
| Pale Fire Capital SE | 221,875 | 1.2M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 187,564 | 980K $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 182,738 | 954.8K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 169,259 | 884.4K $ | as of Mar 31, 2026 |
| FNY Investment Advisers, LLC | 149,761 | 782 $ | as of Mar 31, 2026 |
| STATE STREET CORP | 128,788 | 672.9K $ | as of Mar 31, 2026 |
| 683 Capital Management, LLC | 126,349 | 660.2K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 124,604 | 651.1K $ | as of Mar 31, 2026 |
| Squarepoint Ops LLC | 118,620 | 619.8K $ | as of Mar 31, 2026 |
Declared shareholders of Sagimet Biosciences Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| BlackRock, Inc. | 7.80 % | 4,751,186 | as of Jun 30, 2026 · SCHEDULE 13G |
| BALYASNY ASSET MANAGEMENT L.P. and 4 others | 5.93 % | 3,626,113 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Sagimet Biosciences Inc". https://titelia.com/en/stocks/sagimet-biosciences-inc-US7867001049